share_log

Zevia PBC (NYSE:ZVIA) Price Target Raised to $4.50 at Wells Fargo & Company

Zevia PBC (NYSE:ZVIA) Price Target Raised to $4.50 at Wells Fargo & Company

Zevia PBC(紐約證券交易所代碼：Zvia)富國銀行目標價上調至4.50美元
Defense World ·  2022/10/04 15:52

Zevia PBC (NYSE:ZVIA – Get Rating) had its price target upped by Wells Fargo & Company from $3.50 to $4.50 in a report published on Monday, Stock Target Advisor reports. The firm currently has an equal weight rating on the stock.

據Stock Target Advisor報道，在週一發佈的一份報告中，富國銀行將Zevia PBC(NYSE：Zvia-GET評級)的目標價從3.50美元上調至4.50美元。該公司目前對該股的評級相同。

Separately, Morgan Stanley upped their price objective on Zevia PBC from $3.25 to $3.50 and gave the stock an equal weight rating in a research report on Monday, August 15th. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of Moderate Buy and an average price target of $10.50.

另外，在8月15日週一的一份研究報告中，摩根士丹利將Zevia PBC的目標價從3.25美元上調至3.50美元，並給予該股同等權重的評級。兩名分析師對該股的評級為持有，三名分析師對該公司股票的評級為買入。根據MarketBeat.com的數據，該股目前的平均評級為中等買入，平均目標價為10.50美元。

Get
到達
Zevia PBC
Zevia PBC
alerts:
警報：

Zevia PBC Stock Up 0.9 %

Zevia PBC股票上漲0.9%

NYSE:ZVIA opened at $4.36 on Monday. The stock's fifty day moving average is $4.32 and its two-hundred day moving average is $3.65. Zevia PBC has a 52 week low of $1.86 and a 52 week high of $13.92. The stock has a market capitalization of $299.24 million, a price-to-earnings ratio of -2.27 and a beta of 0.09.

紐約證券交易所：Zvia週一開盤報4.36美元。該股的50日移動均線切入位為4.32美元，200日移動均線切入位為3.65美元。Zevia PBC的52周低點為1.86美元，52周高位為13.92美元。該股市值為2.9924億美元，市盈率為-2.27倍，貝塔係數為0.09。

Insider Transactions at Zevia PBC

Zevia PBC的內幕交易

In related news, Director Padraic L. Spence sold 33,396 shares of the stock in a transaction on Monday, September 19th. The stock was sold at an average price of $4.47, for a total value of $149,280.12. Following the transaction, the director now owns 2,364,472 shares of the company's stock, valued at $10,569,189.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through
在相關新聞中，董事Padraic L.Spence在9月19日(星期一)的一次交易中出售了33,396股該股。這隻股票的平均售價為4.47美元，總價值為149,280.12美元。交易完成後，董事現在持有該公司2364,472股股票，價值10,569,189.84美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過
this link
這個環節
. In related news, Director Padraic L. Spence sold 33,396 shares of the stock in a transaction on Monday, September 19th. The stock was sold at an average price of $4.47, for a total value of $149,280.12. Following the transaction, the director now owns 2,364,472 shares of the company's stock, valued at $10,569,189.84. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through
。在相關新聞中，董事Padraic L.Spence在9月19日(星期一)的一次交易中出售了33,396股該股。這隻股票的平均售價為4.47美元，總價值為149,280.12美元。交易完成後，董事現在持有該公司2364,472股股票，價值10,569,189.84美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的，該文件可通過
this link
這個環節
. Also, Director Padraic L. Spence sold 33,131 shares of the stock in a transaction on Thursday, August 18th. The shares were sold at an average price of $4.85, for a total value of $160,685.35. Following the completion of the transaction, the director now directly owns 2,397,868 shares in the company, valued at approximately $11,629,659.80. The disclosure for this sale can be found
。此外，在8月18日(星期四)的一筆交易中，董事Padraic L.Spence出售了33,131股該股。這些股票的平均價格為4.85美元，總價值為160,685.35美元。交易完成後，董事現在直接擁有該公司2,397,868股，價值約11,629,659.80美元。關於這次銷售的披露可以找到
here
這裏
. Over the last 90 days, insiders have sold 98,971 shares of company stock valued at $410,217. 13.61% of the stock is currently owned by company insiders.
。在過去的90天裏，內部人士出售了98,971股公司股票，價值410,217美元。公司內部人士目前持有該公司13.61%的股份。

Hedge Funds Weigh In On Zevia PBC

對衝基金參與Zevia PBC

Hedge funds have recently made changes to their positions in the company. Cubist Systematic Strategies LLC purchased a new position in shares of Zevia PBC during the second quarter worth about $42,000. Prelude Capital Management LLC purchased a new position in shares of Zevia PBC during the second quarter worth about $47,000. Diversified Trust Co purchased a new position in shares of Zevia PBC during the first quarter worth about $49,000. Qube Research & Technologies Ltd acquired a new stake in shares of Zevia PBC during the first quarter worth about $58,000. Finally, Penserra Capital Management LLC boosted its stake in shares of Zevia PBC by 70.0% during the first quarter. Penserra Capital Management LLC now owns 13,296 shares of the company's stock worth $60,000 after buying an additional 5,476 shares during the period. Hedge funds and other institutional investors own 40.67% of the company's stock.

對衝基金最近對他們在該公司的頭寸進行了調整。Cubist Systems Strategy LLC在第二季度購買了Zevia PBC的新頭寸，價值約42,000美元。Prelude Capital Management LLC在第二季度購買了Zevia PBC的新頭寸，價值約47,000美元。多元化信託公司在第一季度購買了Zevia PBC的新頭寸，價值約49,000美元。Qube Research&Technologies Ltd在第一季度收購了Zevia PBC的新股份，價值約5.8萬美元。最後，Penserra Capital Management LLC在第一季度將其在Zevia PBC的股份增加了70.0%。Penserra Capital Management LLC現在擁有13,296股該公司股票，價值60,000美元，在此期間又購買了5,476股。對衝基金和其他機構投資者持有該公司40.67%的股票。

About Zevia PBC

關於Zevia PBC

(Get Rating)

(獲取評級)

Zevia PBC, a beverage company, develops, markets, sells, and distributes various carbonated and non-carbonated soft drinks in the United States and Canada. It offers soda, energy drinks, organic tea, mixers, kidz beverages, and sparkling water. The company offers its products through various retail channels, including grocery distributors, national retailers, warehouse club, and natural products retailers, as well as e-commerce channels.

Zevia PBC是一家飲料公司，在美國和加拿大開發、營銷、銷售和分銷各種碳酸和非碳痠軟飲料。它提供汽水、能量飲料、有機茶、攪拌器、兒童飲料和蘇打水。該公司通過各種零售渠道提供產品，包括雜貨分銷商、全國零售商、倉儲俱樂部、天然產品零售商以及電子商務渠道。

See Also

另請參閲

  • Get a free copy of the StockNews.com research report on Zevia PBC (ZVIA)
  • Small-Cap Catalyst Pharma Is Among Market's Best Price Performers
  • 3 Stocks Growing Their Businesses for 2023
  • China-Based EV Maker BYD Set For Big European, Japanese Expansion
  • Is Illumina Still the Gamechanger in Genomics Sequencing?
  • Here's What Makes Amazon a Sum-of-All-Parts Commerce Juggernaut
  • 免費獲取StockNews.com關於Zevia PBC的研究報告(Zvia)
  • 小盤股Catalyst Pharma是市場上價格表現最好的公司之一
  • 2023年3只股票實現業務增長
  • 中國電動汽車製造商比亞迪將在歐洲和日本大舉擴張
  • Illumina仍然是基因組測序中的Gamchanger嗎？
  • 以下是亞馬遜成為一個集所有部分於一身的商務巨頭的原因

Receive News & Ratings for Zevia PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zevia PBC and related companies with MarketBeat.com's FREE daily email newsletter.

接受Zevia PBC日報的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Zevia PBC和相關公司的最新新聞和分析師評級的每日簡要摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論